Fundraising Fox

Celerion

Lincoln, US · 3 known investors

Find your way into Celerion

Celerion is a contract research organization specializing in early phase clinical drug development, providing bioanalytical services and laboratory testing that generate clinical data for pharmaceutical clients. It focuses on early stage drug development to help clients make go/no-go decisions and bring drugs to market.

BiotechDigital HealthHealthtechMedical Devices

Investors · 3

H.I.G. CapitalMiami
H.I.G. HealthBridge PartnersMiami · $5M – $40M
SV Health InvestorsBoston · $1M – $20M

In the news

Celerion Receives Investment From THL Partnersfinsmes.com · Apr 2026THL plans $1.8B deal for pharma services firm Celerionaxios.com · Apr 2026THL buying clinical research organization Celerion for $1.8B - THLthl.com · Apr 2026H.I.G. Capital Announces the Sale of Celerionprnewswire.com · Apr 2026

Frequently asked questions

What does Celerion do?
Celerion is a contract research organization specializing in early phase clinical drug development, providing bioanalytical services and laboratory testing that generate clinical data for pharmaceutical clients. It focuses on early stage drug development to help clients make go/no-go decisions and bring drugs to market.
Who are Celerion's investors?
Celerion's investors include H.I.G. Capital, H.I.G. HealthBridge Partners, SV Health Investors.
Where is Celerion headquartered?
Celerion is headquartered in Lincoln, US.